492 related articles for article (PubMed ID: 36747082)
1. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis.
Liu X; Nie L; Zhang Y; Yan Y; Wang C; Colic M; Olszewski K; Horbath A; Chen X; Lei G; Mao C; Wu S; Zhuang L; Poyurovsky MV; James You M; Hart T; Billadeau DD; Chen J; Gan B
Nat Cell Biol; 2023 Mar; 25(3):404-414. PubMed ID: 36747082
[TBL] [Abstract][Full Text] [Related]
2. Disulfidptosis: disulfide stress-induced cell death.
Liu X; Zhuang L; Gan B
Trends Cell Biol; 2024 Apr; 34(4):327-337. PubMed ID: 37574347
[TBL] [Abstract][Full Text] [Related]
3. Disulfidptosis: Six Riddles Necessitating Solutions.
Wang X; Zheng C; Yao H; Guo Y; Wang Y; He G; Fu S; Deng X
Int J Biol Sci; 2024; 20(3):1042-1044. PubMed ID: 38322120
[TBL] [Abstract][Full Text] [Related]
4.
Sun XY; Xiao M; Fu M; Gao Q; Li RF; Wang J; Li SL; Ge XY
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540687
[TBL] [Abstract][Full Text] [Related]
5. Disulfidptosis: a new form of programmed cell death.
Zheng T; Liu Q; Xing F; Zeng C; Wang W
J Exp Clin Cancer Res; 2023 May; 42(1):137. PubMed ID: 37259067
[TBL] [Abstract][Full Text] [Related]
6. The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma.
Qi C; Ma J; Sun J; Wu X; Ding J
Aging (Albany NY); 2023 Jun; 15(11):5075-5095. PubMed ID: 37315289
[TBL] [Abstract][Full Text] [Related]
7. SLC7A11 expression level dictates differential responses to oxidative stress in cancer cells.
Yan Y; Teng H; Hang Q; Kondiparthi L; Lei G; Horbath A; Liu X; Mao C; Wu S; Zhuang L; James You M; Poyurovsky MV; Ma L; Olszewski K; Gan B
Nat Commun; 2023 Jun; 14(1):3673. PubMed ID: 37339981
[TBL] [Abstract][Full Text] [Related]
8. In what area of biology has a "new" type of cell death been discovered?
Wang X; Lin J; Li Z; Wang M
Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188955. PubMed ID: 37451411
[TBL] [Abstract][Full Text] [Related]
9. Disulfidptosis, A Novel Cell Death Pathway: Molecular Landscape and Therapeutic Implications.
Gu Q; An Y; Xu M; Huang X; Chen X; Li X; Shan H; Zhang M
Aging Dis; 2024 May; ():. PubMed ID: 38739940
[TBL] [Abstract][Full Text] [Related]
10. Cystine transporter regulation of pentose phosphate pathway dependency and disulfide stress exposes a targetable metabolic vulnerability in cancer.
Liu X; Olszewski K; Zhang Y; Lim EW; Shi J; Zhang X; Zhang J; Lee H; Koppula P; Lei G; Zhuang L; You MJ; Fang B; Li W; Metallo CM; Poyurovsky MV; Gan B
Nat Cell Biol; 2020 Apr; 22(4):476-486. PubMed ID: 32231310
[TBL] [Abstract][Full Text] [Related]
11. Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions.
Chen J; Ma B; Yang Y; Wang B; Hao J; Zhou X
Biomark Res; 2024 Apr; 12(1):45. PubMed ID: 38685115
[TBL] [Abstract][Full Text] [Related]
12. Pan-cancer and single-cell analysis of actin cytoskeleton genes related to disulfidptosis.
Shen LP; Jiang HT
Open Med (Wars); 2024; 19(1):20240929. PubMed ID: 38584831
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Disulfidptosis-related Genes and Functional Analysis in Gastric Cancer.
Yan J; Fang Z; Shi M; Tu C; Zhang S; Jiang C; Li Q; Shao Y
J Cancer; 2024; 15(4):1053-1066. PubMed ID: 38230212
[No Abstract] [Full Text] [Related]
14. Merlin/NF2 regulates SLC7A11/xCT expression and cell viability under glucose deprivation at high cell density in glioblastoma cells.
Yamaguchi I; Katoh H
J Biochem; 2024 Mar; 175(3):313-322. PubMed ID: 38102738
[TBL] [Abstract][Full Text] [Related]
15. The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.
Koppula P; Zhang Y; Shi J; Li W; Gan B
J Biol Chem; 2017 Aug; 292(34):14240-14249. PubMed ID: 28630042
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer genetic analysis of disulfidptosis-related gene set.
Liu H; Tang T
Cancer Genet; 2023 Nov; 278-279():91-103. PubMed ID: 37879141
[TBL] [Abstract][Full Text] [Related]
17. NFATc1-mediated expression of SLC7A11 drives sensitivity to TXNRD1 inhibitors in osteoclast precursors.
Zhong Z; Zhang C; Ni S; Ma M; Zhang X; Sang W; Lv T; Qian Z; Yi C; Yu B
Redox Biol; 2023 Jul; 63():102711. PubMed ID: 37148740
[TBL] [Abstract][Full Text] [Related]
18. Exploring the role of the disulfidptosis-related gene SLC7A11 in adrenocortical carcinoma: implications for prognosis, immune infiltration, and therapeutic strategies.
Liu T; Ren Y; Wang Q; Wang Y; Li Z; Sun W; Fan D; Luan Y; Gao Y; Yan Z
Cancer Cell Int; 2023 Nov; 23(1):259. PubMed ID: 37919768
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between disulfidptosis and immune check point genes defines the tumor microenvironment for the prediction of prognosis and immunotherapies in glioblastoma.
Zhou Y; Qin X; Hu Q; Qin S; Xu R; Gu K; Lu H
Sci Rep; 2024 Feb; 14(1):3901. PubMed ID: 38365809
[TBL] [Abstract][Full Text] [Related]
20. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.
Koppula P; Zhuang L; Gan B
Protein Cell; 2021 Aug; 12(8):599-620. PubMed ID: 33000412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
